专题：Retinal Diseases and Treatments

This cluster of papers focuses on research related to age-related macular degeneration (AMD) and diabetic retinopathy. It covers topics such as the role of oxidative stress, vascular endothelial growth factor, complement factor H polymorphism, and choroidal thickness in the pathogenesis and treatment of these diseases. Additionally, it explores the use of intravitreal injections and optical coherence tomography angiography in understanding and managing AMD and diabetic retinopathy.
最新文献
AFG Ameliorates Diabetic Retinopathy through AMPK-Dependent Autolysosomal Pathway: From Network Pharmacology to In Vivo and In Vitro Validation

article Full Text OpenAlex

Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database

article Full Text OpenAlex

Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo

article Full Text OpenAlex

New Horizons in Diabetic Neuropathy: Highlights from the 2025 ADA and EASD Conferences

article Full Text OpenAlex

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026

article Full Text OpenAlex

The Role of Complement Activation in Diabetic Nephropathy: Current Insights and Future Directions

review Full Text OpenAlex

Calcium Modification After Orbital Atherectomy and Balloon Angioplasty in Severely Calcified Lesions: The ECLIPSE OCT Substudy

article Full Text OpenAlex

Automated retinal image analysis systems to triage for grading of diabetic retinopathy: a large-scale, open-label, national screening programme in England

article Full Text OpenAlex

PSCP, a novel reactive sulfur donor, activates Keap1-Nrf2 signaling and attenuates mitochondrial dysfunction in diabetic retinopathy

article Full Text OpenAlex

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

article Full Text OpenAlex

近5年高被引文献
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets

review Full Text OpenAlex 790 FWCI170.8444

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

article Full Text OpenAlex 625 FWCI117.2106

Optical Coherence Tomography of Ocular Diseases

book Full Text OpenAlex 482 FWCI19.68

Diabetic retinopathy: Looking forward to 2030

review Full Text OpenAlex 428 FWCI122.2545

Glaucoma: now and beyond

review Full Text OpenAlex 428 FWCI121.3825

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

article Full Text OpenAlex 398 FWCI76.1767

Age-related macular degeneration

review Full Text OpenAlex 395 FWCI116.5946

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

article Full Text OpenAlex 384 FWCI108.6707

Age-Related Macular Degeneration

review Full Text OpenAlex 377 FWCI218.5581

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

review Full Text OpenAlex 356 FWCI100.7468